General Information of the Compound
Compound ID
CP0123984
Compound Name
(S)-1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic acid [(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide
    Show/Hide
Synonyms
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
(S)-N-((S)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide
141801-26-5
3PH5M0466G
CHEMBL333357
ENDOMORPHIN 2
Endomorphin 2
Endomorphin-2
H-Tyr-Pro-Phe-Phe-NH2
L-Phenylalaninamide,L-tyrosyl-L-prolyl-L-phenylalanyl-
UNII-3PH5M0466G
    Show/Hide
Structure
Formula
C32H37N5O5
Molecular Weight
571.678
Canonical SMILES
N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
    Show/Hide
InChI
InChI=1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1
    Show/Hide
InChIKey
XIJHWXXXIMEHKW-LJWNLINESA-N
Physicochemical Property
logP
1.1933
Rotatable Bonds
12
Heavy Atom Count
42
Polar Areas
167.85
Hydrogen Bond Donor Count
5
Hydrogen Bond Acceptor Count
6
Complexity
42

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5311081
SID: 14764280
ChEMBL ID
CHEMBL333357
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  3
1
EC50 > 1000 nM
   TI
   LI
   LO
   TS
2
Ki = 3385 nM
   TI
   LI
   LO
   TS
3
Ki = 7899 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 6420 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 6085 nM
Protein ID: PT00983, Kappa-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
Ki = 1136 nM
   TI
   LI
   LO
   TS
2
Ki > 500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 5240 nM
Protein ID: PT01515, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  7
1
EC50 = 0.04 nM
   TI
   LI
   LO
   TS
2
EC50 = 1.55 nM
   TI
   LI
   LO
   TS
3
EC50 = 5.754 nM
   TI
   LI
   LO
   TS
4
EC50 = 13.18 nM
   TI
   LI
   LO
   TS
5
EC50 = 13.8 nM
   TI
   LI
   LO
   TS
6
Ki = 2.95 nM
   TI
   LI
   LO
   TS
7
Ki = 5.3 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  4
1
EC50 = 11.8 nM
   TI
   LI
   LO
   TS
2
EC50 = 15.7 nM
   TI
   LI
   LO
   TS
3
EC50 = 55.5 nM
   TI
   LI
   LO
   TS
4
Ki = 3.2 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 0.69 nM
2 Ki = 1.33 nM
3 Ki = 8.23 nM
Clinical Information about the Compound
Drug 1 ( ENDOMORPHIN 2 )
Drug Name ENDOMORPHIN 2
Target(s)
Opioid receptor kappa (OPRK1)
Inhibitor
Substance-P receptor (TACR1)
Inhibitor
Opioid receptor mu (MOP)
Inhibitor
Opioid receptor delta (OPRD1)
Inhibitor